CACNA1C and cardiac hypertrophy: In addition, Cav1.2 blockade has shown beneficial effects in animal models of hypertension by preventing intracellular calcium overload in cardiomyocytes, resulting in less cardiac remodeling, cardiac hypertrophy and diastolic dysfunction [65].